NAGS and glioblastoma: There was a trend (p = 0.07) towards a worse outcome (shorter survival time) for patients with glioblastoma multiforme exhibiting the highest expression of NAGS mRNA, compared to glioblastoma multiforme patients exhibiting the lowest expression of NAGS mRNA (Figure 2D).